TO ACHIEVE MAXIMUM RESULTS, IT IS RECOMMENDED THAT PATIENTS BEGIN TREATMENT WITH PRESCRIPTION STRENGTH DERMAZINC™. FOR ADDITIONAL INFORMATION, ASK A HEALTH CARE PROFESSIONAL.
Dermalogix Partners, Inc. patented formulation of medicated over the counter (OTC) DermaZinc™ Cream is recommended for use for patients whose skin is sensitive to alcohol, which acts as a vehicle in DermaZinc™ Spray/Drops. DermaZinc™ Cream is extremely effective in treating red flaky, itchy, scaly skin associated with mild to moderate cases of eczema, psoriasis, and seborrheic dermatitis. Many patients have reported successful results using DermaZinc™ Cream for treating acne and fungal conditions. It is also safe to use on pediatrics that suffer from diaper rash or cradle cap.
DermaZinc™ Cream features a high emollient base for skin moisturizing and 0.25% zinc pyrithione. DermaZinc™ Cream is non-oily, has no lingering odor and is safe to use daily. To achieve maximum results it is recommended that DermaZinc™ Cream to be applied twice daily on affected areas.
IMPORTANT: Patients suffering with severe cases of eczema, psoriasis and seborrheic dermatitis, the use of prescription strength DermaZinc™ Cream is recommended. DermaZinc™ Cream compounded with 77mg of Micronized Betamethasone Diproprionate USP is prescribed by your doctor, used twice daily for up to two weeks. Once skin is cleared, maintain healthy skin by using OTC DermaZinc™ products a minimum of three times a week.
Pharmacist and Doctors, please see compounding instructions or call 1-800-753-0047 for more information. To achieve maximum results, Micronized Powder Betamethasone Diproprionate USP should be used.
For additional product information, usage and product warnings, click here.